Piperazinyltriazines as estrogen receptor modulators

Triazine derivatives of formula (I), which exhibit pharmacological activity at estrogen receptors alpha (ER alpha) and beta (ER beta) are described herein. The described invention also includes compositions and medicaments containing the triazine derivatives as well as processes for the preparation...

Full description

Saved in:
Bibliographic Details
Main Authors Hale, Ronnie Lee, Henke, Brad Richard, Lambert, III, Millard Hurst, Lu, Amy Tsai, Spearing, Paul Kenneth, Turnbull, Philip Stewart
Format Patent
LanguageEnglish
Published 13.09.2005
Online AccessGet full text

Cover

More Information
Summary:Triazine derivatives of formula (I), which exhibit pharmacological activity at estrogen receptors alpha (ER alpha) and beta (ER beta) are described herein. The described invention also includes compositions and medicaments containing the triazine derivatives as well as processes for the preparation and use of such compounds, compositions and medicaments.